Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,237 INR | +3.01% | -3.38% | +12.82% |
Sales 2024 * | 103B 1.23B | Sales 2025 * | 117B 1.4B | Capitalization | 896B 10.73B |
---|---|---|---|---|---|
Net income 2024 * | 18.3B 219M | Net income 2025 * | 21.75B 261M | EV / Sales 2024 * | 8.44 x |
Net cash position 2024 * | 25.25B 302M | Net cash position 2025 * | 43.42B 520M | EV / Sales 2025 * | 7.31 x |
P/E ratio 2024 * |
48.9
x | P/E ratio 2025 * |
41.1
x | Employees | 18,468 |
Yield 2024 * |
0.31% | Yield 2025 * |
0.43% | Free-Float | 19.91% |
Latest transcript on Mankind Pharma Limited
1 day | +3.01% | ||
1 week | -3.38% | ||
Current month | -5.40% | ||
1 month | -5.57% | ||
3 months | +1.16% | ||
6 months | +22.01% | ||
Current year | +12.82% |
Managers | Title | Age | Since |
---|---|---|---|
Sheetal Arora
CEO | Chief Executive Officer | 48 | 07-09-20 |
Ashutosh Dhawan
DFI | Director of Finance/CFO | 55 | 16-06-16 |
Pradeep Chugh
CMP | Compliance Officer | - | 16-09-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vivek Kalra
BRD | Director/Board Member | 60 | 22-07-31 |
Vijaya Sampath
BRD | Director/Board Member | 71 | 22-07-31 |
Surendra Lunia
BRD | Director/Board Member | 61 | 15-02-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2,237 | +3.01% | 250,646 |
24-05-09 | 2,171 | -0.52% | 456,258 |
24-05-08 | 2,183 | -1.56% | 454,898 |
24-05-07 | 2,217 | -3.04% | 407,210 |
24-05-06 | 2,287 | -1.22% | 485,808 |
Delayed Quote NSE India S.E., May 10, 2024 at 07:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.82% | 10.73B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- MANKIND Stock